Clinical Trials List
2021-11-01 - 2026-08-02
Phase II
Recruiting3
ICD-10C43.9
Malignant melanoma of skin, unspecified
ICD-10D03.9
Melanoma in situ, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9172.9
Malignant melanoma of skin, site unspecified
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
180 participants
